SCHEMBL7691983

SCHEMBL7691983

CC(C)[C@H](NC(=O)OCc1ccccc1)C(=O)OCn1cc(C(=O)OCI)ccc1=O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.50
CYP2D6 P10635 1/20 0.50
CYP2C9 P11712 1/20 0.50
CYP2C19 P33261 1/20 0.50
RAB9A P51151 1/20 0.50
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
IL1RN P18510 1/20 0.43
ERAP2 Q6P179 1/20 0.43
ERAP1 Q9NZ08 1/20 0.43
CTSB P07858 5/20 0.43
CTSK P43235 4/20 0.43
CTSS P25774 4/20 0.43
CTSL P07711 4/20 0.43
CASP3 P42574 2/20 0.42
CASP1 P29466 1/20 0.42
CASP7 P55210 1/20 0.42
CASP6 P55212 1/20 0.42
CASP8 Q14790 1/20 0.42
ELANE P08246 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3739447 0.91 MEN1 (0.45) CYP3A4CYP2D6CYP2C9CYP2C19RAB9A
SCHEMBL3726974 0.84 CYP3A4 (0.54) CYP3A4CYP2D6CYP2C9CYP2C19RAB9A
SCHEMBL3727821 0.81 MEN1 (0.45) CYP3A4CYP2D6CYP2C9CYP2C19RAB9A
SCHEMBL2150881 0.80 CTSB (0.58) CYP3A4CYP2D6CYP2C9CYP2C19RAB9A
SCHEMBL22685692 0.80 CTSB (0.58) CYP3A4CYP2D6CYP2C9CYP2C19RAB9A
SCHEMBL2150884 0.80 CTSB (0.58) CYP3A4CYP2D6CYP2C9CYP2C19RAB9A
SCHEMBL3732282 0.80 MEN1 (0.48) CYP3A4CYP2D6CYP2C9CYP2C19RAB9A
SCHEMBL3729371 0.79 CTSD (0.46) CYP3A4CYP2D6CYP2C9CYP2C19RAB9A
SCHEMBL2221511 0.78 CTSB (0.56) CYP3A4CYP2D6CYP2C9CYP2C19RAB9A
SCHEMBL3726931 0.75 CTSL (0.48) RAB9AMEN1KMT2ACTSBCTSK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6458772-B1 Prodrugs MEDIVIR AB (SE) 2002-10-01 US disclosed